20 ML Empaveli 54 MG/ML Injection
- RxCUI
- 2557391
- RxNorm name
- 20 ML Empaveli 54 MG/ML Injection
- Display name
- 20 ML Empaveli 54 MG/ML Injection
- Full name
- 20 ML Empaveli 54 MG/ML Injection
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:19
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Empaveli | PEGCETACOPLAN | Apellis Pharmaceuticals, Inc. | c23d89e9-b00b-4520-e053-2995a90a95af | 2026-08-21 | Boxed warning, Warnings, Adverse reactions | 2557391 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| c23d89e9-b00b-4520-e053-2995a90a95af | EMPAVELI 1080 MG in 20 ML Injection [PSN] · 20 ML pegcetacoplan 54 MG/ML Injection [Empaveli] [SBD] · 20 ML Empaveli 54 MG/ML Injection [SY] · Empaveli 1080 MG per 20 ML Injection [SY] | 4 | 13 | These highlights do not include all the information needed to use EMPAVELI safely and effectively. See full prescribing information for EMPAVELI. EMPAVELI ® (pegcetacoplan) injection, for subcutaneous use Initial U.S. Approval: 2021 | 20250730 |